Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Clinical Chemistry

Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

An Alzheimer’s blood test becomes the first cleared by FDA for symptomatic adults as young as 40. More...
21 Aug 2026
Image Credit: Adobe Stock

Simple Whole-Blood Screen Identifies Elevated Bile Acids Linked to Liver Disease

A whole-blood test rapidly flags elevated bile acids before routine liver markers rise. More...
20 Aug 2026
Image:  Estimates suggest that 30–50% of CKD cases go undiagnosed in high‑income countries, with even higher proportions likely in middle‑ and lower‑income countries (Image Credit: Shutterstock)

Routine Urine Protein Testing Identifies Undiagnosed Chronic Kidney Disease

New findings reveal up to half of CKD cases go undetected, urging routine urine protein testing to improve early detection. More...
20 Aug 2026
Image Credit: 123RF

Longitudinal Heart Stress Assessment Improves Prediction of Cardiovascular Outcomes

Serial NT-proBNP testing may improve CVD and mortality risk stratification in older adults. More...
20 Aug 2026
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

A new blood test measuring tumor cell growth may guide treatment sequencing in genetically defined metastatic melanoma. More...
20 Aug 2026
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

A new handheld breath sensor detects SARS‑CoV‑2 from exhaled air with near‑instant, selective readouts. More...
18 Aug 2026
Image: The findings support integrating high-performing plasma p-tau217 assays into Alzheimer’s diagnostic workflows, provided that platform-specific calibration and standardized testing protocols are in place. (Image Credit: Adobe Stock)

Head-to-Head Study Compares Blood Tests for Early Alzheimer’s Disease Detection

New findings show leading plasma p-tau217 assays detect amyloid with varying accuracy, urging platform-specific calibration. More...
18 Aug 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.


The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.